6月27日A股投資避雷針︱龍津退:公司股票終止上市暨摘牌;*ST高鴻:及控股子公司被納入失信被執行人名單
國脈科技股東國脈集團擬減持不超1007.5萬股;國際復材股東雲南雲熹合計減持1727.64萬股;開潤股份控股股東、實控人範勁松擬減持不超2%股份;三友聯眾股東寧波昊與軒及寧波艾力美擬減持合計不超3%股份;匯綠生態大股東/實際控制人的一致行動人擬減持不超過3%股份;福光股份股東國資公司擬合計減持不超3.00%股份;江南奕帆持股5%以上股東、董事陳淵技和龔建芬合計減持2.9665%股份;紐威股份表示紐威集團擬減持不超0.97%股份;*ST高鴻及控股子公司被納入失信被執行人名單;龍津退公司股票終止上市暨摘牌

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.